Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

Estimating lifetime or episode-of-illness costs under censoring.

Basu A, Manning WG.

Health Econ. 2010 Sep;19(9):1010-28. doi: 10.1002/hec.1640. Erratum in: Health Econ. 2011 Jan;20(1):125-6.

PMID:
20665908
2.

Inverse probability weighted least squares regression in the analysis of time-censored cost data: an evaluation of the approach using SEER-Medicare.

Griffiths RI, Gleeson ML, Danese MD, O'Hagan A.

Value Health. 2012 Jul-Aug;15(5):656-63. doi: 10.1016/j.jval.2012.03.1388. Epub 2012 Jun 22.

3.

Regression analysis of incomplete medical cost data.

Lin DY.

Stat Med. 2003 Apr 15;22(7):1181-200.

PMID:
12652561
4.

Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.

Goodman AC, Hankin JR, Kalist DE, Peng Y, Spurr SJ.

J Ment Health Policy Econ. 2001 Jun 1;4(2):65-77.

PMID:
11967467
5.

Estimation for the optimal combination of markers without modeling the censoring distribution.

Chiang CT, Huang SY.

Biometrics. 2009 Mar;65(1):152-8. doi: 10.1111/j.1541-0420.2007.01040.x. Epub 2008 Apr 16.

PMID:
18422791
6.

Measuring costs: administrative claims data, clinical trials, and beyond.

Etzioni R, Riley GF, Ramsey SD, Brown M.

Med Care. 2002 Jun;40(6 Suppl):III63-72. Review.

PMID:
12064760
7.

A two-part model for censored medical cost data.

Tian L, Huang J.

Stat Med. 2007 Oct 15;26(23):4273-92.

PMID:
17330248
8.

Comparison of approaches for estimating incidence costs of care for colorectal cancer patients.

Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML.

Med Care. 2009 Jul;47(7 Suppl 1):S56-63. doi: 10.1097/MLR.0b013e3181a4f482.

PMID:
19536010
9.

Longitudinal analysis of censored medical cost data.

Başer O, Gardiner JC, Bradley CJ, Yüce H, Given C.

Health Econ. 2006 May;15(5):513-25.

PMID:
16389670
10.

A shared random effects model for censored medical costs and mortality.

Liu L, Wolfe RA, Kalbfleisch JD.

Stat Med. 2007 Jan 15;26(1):139-55.

PMID:
16526006
11.

Prostate cancer--prevalence-based healthcare costs.

Norlund A, Alvegård T, Lithman T, Merlo J, Noreen D.

Scand J Urol Nephrol. 2003;37(5):371-5.

PMID:
14594683
12.
13.

Estimating episode lengths when some observations are probably censored.

Goodman AC, Peng Y, Hankin JR, Kalist DE, Spurr SJ.

Stat Med. 2004 Jul 15;23(13):2071-87.

PMID:
15211604
14.

Comparison of dynamic treatment regimes via inverse probability weighting.

Hernán MA, Lanoy E, Costagliola D, Robins JM.

Basic Clin Pharmacol Toxicol. 2006 Mar;98(3):237-42. Review.

15.

Estimating mean cost using auxiliary covariates.

Pan W, Zeng D.

Biometrics. 2011 Sep;67(3):996-1006. doi: 10.1111/j.1541-0420.2010.01540.x. Epub 2011 Jan 6.

PMID:
21210773
16.

Estimating medical costs from incomplete follow-up data.

Lin DY, Feuer EJ, Etzioni R, Wax Y.

Biometrics. 1997 Jun;53(2):419-34.

PMID:
9192444
17.
18.

Estimating stage occupation probabilities in non-Markov models.

Gunnes N, Borgan O, Aalen OO.

Lifetime Data Anal. 2007 Jun;13(2):211-40. Epub 2007 Mar 2.

PMID:
17334924
19.

Semiparametric analysis of survival data with left truncation and dependent right censoring.

Jiang H, Fine JP, Chappell R.

Biometrics. 2005 Jun;61(2):567-75.

PMID:
16011706
20.

Supplemental Content

Support Center